CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

Abstract

In chronic infections and in cancer, persistent antigen stimulation under suboptimal conditions can lead to the induction of T-cell exhaustion. Exhausted T cells are characterized by an increased expression of inhibitory markers and a progressive and hierarchical loss of function. Although cancer-induced exhaustion in CD8 T cells has been well-characterized and identified as a therapeutic target (i.e., via checkpoint inhibition), in-depth analyses of exhaustion in other immune cell types, including CD4 T cells, is wanting. While perhaps attributable to the contextual discovery of exhaustion amidst chronic viral infection, the lack of thorough inquiry into CD4 T-cell exhaustion is particularly surprising given their important role in orchestrating immune responses through T-helper and direct cytotoxic functions. Current work suggests that CD4 T-cell exhaustion may indeed be prevalent, and as CD4 T cells have been implicated in various disease pathologies, such exhaustion is likely to be clinically relevant. Defining phenotypic exhaustion in the various CD4 T-cell subsets and how it influences immune responses and disease severity will be crucial to understanding collective immune dysfunction in a variety of pathologies. In this review, we will discuss mechanistic and clinical evidence for CD4 T-cell exhaustion in cancer. Further insight into the derivation and manifestation of exhaustive processes in CD4 T cells could reveal novel therapeutic targets to abrogate CD4 T-cell exhaustion in cancer and induce a robust antitumor immune response.

Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients

“…While these differences were not found in the peripheral blood of treated animals, we did find a slight increase in CD8+ PD-1+ T cells, while CD4+ PD-1+ T cells were decreased ( Figure 5 ). T cell exhaustion is characterized by increased amounts of inhibitory surface receptors, one of them being PD-1 ( 56 ). This finding thus points towards a potential inhibition of cytotoxic T cells, while the activity of CD4+ T cells is not compromised by LDRT.…”

Recent Progress on Therapeutic Vaccines for Breast Cancer

“…CD4+ T cells can enhance the tumoricidal activity of other antitumor effector cells, such as CD8+ T cells and macrophages. Some CD4+ subsets influence angiogenesis to facilitate the infiltration of CD8+ T cells, in addition to direct cytotoxic functions ( 71 ). There are attempts to activate both CD4+ and CD8+ T cells by using multivalent synthetic long peptides (SLPs) containing both MHC class I and class II epitopes ( 72 ).…”

Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy

“…However, the negative effects of CD4 + T cell exhaustion on proliferation, cytokine production, B-cell help, and CD8 + effector functions have been reported. Furthermore, exhausted CD4 + T cells upregulate immune-regulatory proteins, such as TIM3 and PD-1, paralleling phenotypes observed in exhausted CD8 + T cells [ 62 ]. Unlike non-HPD patients, HPD patients showed abnormal dilation of peripheral exhausted memory CD4 + T cells after the initial administration of anti-PD-1/PD-L1 antibodies [ 60 ].…”